SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Sales for the quarter ended September 2023 of Rs. 1792.20 millions rose by 30.87% from Rs. 1369.50 millions.An average growth of 42.76% was recorded for the quarter ended September 2023 to Rs. 821.00  millions from Rs. 575.10 millions.OP of the company witnessed a marginal growth to 1139.40 millions from 798.70 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1792.20 1369.50 30.87 3528.80 2533.40 39.29 5286.10 5280.60 0.10
Other Income 244.90 224.50 9.09 517.60 574.20 -9.86 990.00 565.50 75.07
PBIDT 1139.40 798.70 42.66 2178.30 1609.50 35.34 3189.20 2761.70 15.48
Interest 0.20 0.40 -50.00 0.50 0.50 0.00 1.20 0.90 33.33
PBDT 1139.20 798.30 42.70 2177.80 1609.00 35.35 3188.00 2760.80 15.47
Depreciation 67.20 65.10 3.23 133.90 128.80 3.96 256.50 257.70 -0.47
PBT 1072.00 733.20 46.21 2043.90 1480.20 38.08 2931.50 2503.10 17.11
TAX 251.00 158.10 58.76 460.20 272.70 68.76 588.90 624.40 -5.69
Deferred Tax -19.90 -17.10 16.37 -29.70 -45.10 -34.15 -76.90 8.20 -1037.80
PAT 821.00 575.10 42.76 1583.70 1207.50 31.16 2342.60 1878.70 24.69
Equity 151.90 151.60 0.20 151.90 151.60 0.20 151.80 151.60 0.13
PBIDTM(%) 63.58 58.32 9.01 61.73 63.53 -2.84 60.33 52.30 15.36

Caplin Point Labs. Share Price

2562.15 -62.00 (-2.36%)
01-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1865.95
Dr. Reddys Labs. 1339.35
Cipla 1456.95
Zydus Lifesciences 1108.85
Lupin 2396.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: